Sponsored Ad

RQHTF Site  |  About  |  Overview  |  News                                                        Get FinancialNewsMedia.com Alerts 

Privacy Policy

Reliq Health Technologies Inc. (OTCQB: RQHTF) (TSX-V:RHT) Breaking News -
November 30, 2017


 

Reliq Health Reaches over 4,000 Patients Live on Its iUGO Care Platform, Will Achieve Breakeven in December 2017


VANCOUVER, BC,  - November 30, 2017 - Reliq Health Technologies Inc. (TSX-V:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) solutions for Community-Based Healthcare, is pleased to announce that it now has over 4,000 paid subscribers using its iUGO Care chronic care management, remote patient monitoring and telemedicine platform. This represents recurring monthly revenue of over US$200,000/month; as a result the Company will reach its breakeven point in December 2017.

“We are excited to announce that we now have over 4,000 patients live on our iUGO Care platform,” said Dr. Lisa Crossley, CEO of Reliq Health. “The onboarding of patients is starting to accelerate as we move forward with our roll out to over 40,000 patients with the two current contracts in Texas. We are also very pleased to announce that we have achieved another critical milestone, as the Company will reach breakeven in December 2017. We continue to focus our efforts on the front line care providers in the US who are serving the over 37 Million Medicare and Medicaid patients who have two or more chronic diseases such as diabetes, hypertension, chronic obstructive pulmonary disease (COPD) and congestive heart failure. This market will continue to grow as the population ages and expands, and as pressure from lawmakers and insurers to reduce healthcare spending increases. Our iUGO Care platform allows healthcare providers to proactively manage complex chronic care patients in the lower cost community setting, reducing the need for costly acute interventions such as hospital stays, surgeries, long term care admissions and ER visits.”

Reliq’s iUGO Care digital health solution provides high quality virtual care in the community by creating a “virtual hospital ward” within the patient’s home, automatically collecting vital signs and encouraging and tracking medication adherence. iUGO Care’s unique interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness activities. iUGO Care’s two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions. Reliq’s iUGO Care cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs, preventing costly and disruptive hospital readmissions and ER visits.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information contact:

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

 

Reliq Health Announces Call-In Details for Quarterly Reporting Call, and Launch of New iUGO Care Website


VANCOUVER, BC,  - November 24, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) solutions for Community-Based Healthcare, will host an investor update conference call to review the Company’s recent progress and answer questions from shareholders.

Conference Call Information:

When: December 1, 2017, 8:00am – 9:00am PST / 11:00am – noon EST
ID: 3298828
Dial In: Canada and U.S. - (844) 461-9931 International - (636) 812-6630

The Company would like to advise participants to join the conference call at least 10 minutes early in order to register. Investors are encouraged to submit questions in advance to info@reliqhealth.com as these questions will be addressed first, following which the moderator will open up the call to questions from investors who have registered and joined the queue. To join the queue participants will be asked to key in *1 at any point in the call. Once the questions submitted in advance via email have been addressed, the moderator will open the line to callers in the queue one at a time in order of priority. A recording of the conference call will be available afterwards until December 8, 2017, and will be accessible by calling either of the following numbers: (855) 869-2056 or (404) 537-3406.

Reliq is also pleased to announce that it has launched a new website for its iUGO Care product platform at www.iugocare.com. The new website is intended to support Reliq’s business development and customer outreach efforts and increase product brand awareness. The site provides detailed information on the iUGO Care product line, cloud platform, cybersecurity, company partners and customer testimonials.

Reliq’s iUGO Care digital health solution provides high quality virtual care in the community by creating a “virtual hospital ward” within the patient’s home, automatically collecting vital signs and tracking medication adherence. iUGO Care’s interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness activities. iUGO Care’s two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions. Reliq’s iUGO Care cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs and preventing costly and disruptive hospital readmissions and ER visits.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

 

Reliq Health Technologies Reaches over 2,000 Patients Live on Its iUGO Care Platform
 

VANCOUVER, BC,  - November 16, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) solutions for Community-Based Healthcare, is pleased to announce that it now has over 2,000 paid subscribers using its iUGO Care chronic care management, remote patient monitoring and telemedicine platform, representing recurring monthly revenue of over US$100,000/month.

“We are excited to announce that we now have over 2,000 patients live on our iUGO Care platform,” said Dr. Lisa Crossley, CEO of Reliq Health. “The onboarding of patients is starting to accelerate as we move forward with our roll out to over 40,000 patients in Texas. We expect to continue to enrol more than 1,000 new patients per month through 2018 with our two contracts with Paz Home Health, LLC (Pharr, TX) and Rio Grande Valley Health Alliance, LLC (McAllen, TX), which together are worth over US$26 Million annually in recurring revenue at full deployment. We are proud to offer a solution that comprehensively and cost-effectively addresses the needs of front line care providers in the community and the more than 37 Million Medicare and Medicaid patients who have two or more chronic conditions.”

Reliq is also pleased to announce that it has launched a new version of its corporate website, incorporating improusiness model and provide an industry-leading resource for information on the Community Healthcare market.

Reliq’s iUGO Care digital health solution provides high quality virtual care in the community by creating a “virtual hospital ward” within the patient’s home, automatically collecting vital signs and tracking medication adherence. iUGO Care’s interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness activities. iUGO Care’s two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions. Reliq’s iUGO Care cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs and preventing costly and disruptive hospital readmissions and ER visits.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

 

Reliq Health Announces Receipt of Second Milestone Payment from NextGen, and Upcoming Investor Call
 

VANCOUVER, BC,  - November 9, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative remote patient monitoring, care coordination and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has received the second milestone payment from NextGen Applications LLC of San Antonio, TX (“NextGen” - NextGenApplicationsLLC.com, info@nextgenapplicationsllc.com) per the contract between Reliq and NextGen. The contract, whose total value is $1.22 Million USD, provides NextGen with professional services and a limited license to Reliq’s proprietary iUGO Care platform, specifically for the development of a consumer focused mobile health app (“mTelecare App”), providing service to the greater San Antonio area before expanding elsewhere throughout the U.S.

“We are pleased to have achieved the second milestone in this contract on schedule,” said Dr. Lisa Crossley, CEO of Reliq Health. “NextGen’s initiative to improve health outcomes and enhance access to care through the mTelecare App is directly aligned with Reliq’s focus on Community-Based Healthcare. Working in conjunction with NextGen Applications, we will be able to leverage our existing platform to create a customized mobile health app that will allow the residents of San Antonio and elsewhere to proactively manage their own health.”

“NextGen’s partnership with Reliq Health will allow us to utilize their existing mHealth platform to provide a novel, innovative mobile healthcare solution to the citizens of San Antonio and surrounding area,” said a spokesperson of NextGen Applications. “The resulting mTelecare mobile app will provide a telemedicine platform that connects patients to doctors and nurses anywhere where there is internet access. mTelecare will support secure video consults for patients with doctors and nurses, providing patients with professional care from the comfort of their own home. The mTelecare app will also provide automated prescription refills, search tools for healthcare services, a personalized health calendar with push notifications, reminders and a suite of billing and payment tools. mTelecare will provide greater access to healthcare, while at the same time reducing healthcare costs.”

The City of San Antonio, Texas is the seventh most populated city in the United States and the second most populated city in Texas, with a population of over 1.4 Million residents.

The Company is also pleased to announce that it will be hosting a investor call on December 1, 2017 at 8:00am PST/11:00am EST. Please visit the Company’s website (www.reliqhealth.com) the week of November 20, 2017 for call in details and information on how to submit your questions electronically in advance of the call.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

SOURCE: Reliq Health Technologies Inc.


____________________
Recent RQHTF News:

 

Reliq Health Technologies Announces Closing of Oversubscribed $5 Million Brokered Private Placement
 

VANCOUVER, BC,  - November 2, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce further to its news releases dated October 11 and 30, 2017, it successfully closed an oversubscribed private placement (the “Offering”) led by Canaccord Genuity Corp and Gravitas Securities Inc. (together, the “Co-Lead Agents”) and Beacon Securities Limited (“Beacon” and together with the Co-Lead Agents, the “Agents”) of 12,500,000 Units (the “Units”) of the Company at a price of $0.40 per Unit (the “Unit Price”) for gross proceeds of $5,000,000.

Each Unit consists of one (1) common share of the Company (a “Common Share”) and half of one (1/2) Common Share purchase warrant (each whole Common Share purchase warrant, a “Warrant”). Each of the 6,250,000 Warrants is exercisable to acquire one Common Share (a “Warrant Share”) for a period of two years following the closing date of the Offering at an exercise price of $0.60 per Warrant Share,
subject to adjustment in certain events.

“We are very pleased to have completed a successful oversubscribed financing and to have three of Canada’s leading independent rokerage firms support the Company,” said Dr. Lisa Crossley, CEO of Reliq.

The Company intends to use the net proceeds of the Offering for general working capital, product development and customer acquisition.

In connection with the Offering, the Company paid the Agents a cash fee of $340,000 and issued 625,000 Units to the Agents. Additionally, the Company issued 850,000 compensation warrants to the Agents and other selling dealer group members (the “Compensation Warrants”), with each Compensation Warrant entitling the holder to purchase one Unit of the Company at an exercise price of $0.40 for a period of two years following the closing date of the Offering. Each warrant issued under the Units is exercisable into one Common Share of the Company for a period of two years following the exercise of the Compensation Warrant at an exercise price of $0.60 per Common Share, subject to adjustment in certain events.

All securities issued in connection with the Offering are subject to a four month hold period expiring March 3, 2018.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

SOURCE: Reliq Health Technologies Inc.

 

Reliq Health Technologies Corrects Offering Size of Brokered Private Placement and Announces Exercise of Over-Allotment Option
 

VANCOUVER, BC,  - October 24, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, wishes to clarify its news release on October 17, 2017. The Company intends to offer a private placement financing of up 10,000,000 units of the Company (the “Units”) at a price of $0.40 per Unit for gross proceeds of $4,000,000 (the “Offering”). The Offering is led by Canaccord Genuity Corp. and Gravitas Securities Inc. (collectively, the “Agents”).

Each Unit will consist of one (1) common share of the Company (a “Common Share”) and half of one (1/2) Common Share purchase warrant (each whole Common Share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one Common Share (a “Warrant Share”) for a period of two years following the closing date of the Offering at an exercise price of $0.60 per Warrant Share, subject to adjustment in certain events.

The Company has granted the Agents an over-allotment option (the “Over-Allotment Option”), which may be exercised in the Agents’ sole discretion and without obligation, exercisable in whole or in part and in one or more tranches at any time and from time to time prior to the closing of the Offering, to offer up to an additional 25% of the Units sold under the Offering, with the same terms and conditions as the Units. The Agents have elected to exercise the Over-Allotment Option in full to offer an additional 2,500,000 Units under the Offering. This will raise additional gross proceeds of $1,000,000, resulting in a total gross proceeds of up to $5,000,000 to be raised under the Offering.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information contact:
CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

Source: Reliq Health Technologies Inc.

 

Reliq Health Technologies CEO, Dr. Lisa Crossley, to Present at StableView TECH17
 

VANCOUVER, BC,  - October 24, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that the Company’s CEO Dr. Lisa Crossley will be presenting at the StableView Asset Management TECH17 Conference in Toronto, ON on Thursday, October 26, 2017 at 10:45am.

“We are excited to be a part of StableView’s annual conference and look forward to sharing our progress and business plan for growth with attendees,” said Reliq Health CEO, Dr. Lisa Crossley.

About StableView TECH17

StableView Asset Management hosts StableView TECH17. The 4th annual StableView TECH17 showcases the most innovative ideas, themes and challenges in Technology today. As the only buy-side curated tech conference in Canada, StableView TECH17 sits at the junction of the public and private investing tech ecosystem in Canada and brings together participants that typically stay in their individual silos: institutional investors, pensions, VCs, broker-dealers, advisors, HNW investors and family offices with private and public tech companies in Canada.

On October 26th, 2017, approximately 25 of Canada's leading technology companies will be presenting to an expected audience of over 450+ professionals representing approximately $350B in AUM.

About Reliq Health Technologies

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq's powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. Our platform provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

For further information contact:

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.


Source: Reliq Health Technologies Inc.

 

Reliq Health Technologies Announces Upsize of Previously Announced Private Placement Financing to $5.0 Million
 

VANCOUVER, BC,  - October 17, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that due to high demand it has amended the terms of its previously announced private placement financing to increase the size of the offering from $4,000,000 to $5,000,000 (the "Upsized Offering").

Under the terms of the Upsized Offering Canaccord Genuity Corp. and Gravitas Securities Inc. have been engaged to act as co-lead agents on a commercially reasonable efforts basis in respect to a brokered private placement offering of up to 12,500,000 units (the "Units") at a price of $0.40 per Unit for gross proceeds of up to $5,000,000 (the "Offering") subject to completion of satisfactory due diligence. Each Unit will consist of one (1) common share in the capital of the Company (a "Share") and one-half (1/2) transferable common share purchase warrant (each whole warrant, a "Warrant"), with each Warrant exercisable into one additional Share at a price of $0.60 for a period of two years from the date of closing. The Company intends to use the net proceeds of the offering for general working capital, product development and customer acquisition.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information contact:
CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.


Source: Reliq Health Technologies Inc.

 

Reliq Health Technologies Announces $4,000,000 Brokered Private Placement Co-led by Canaccord Genuity and Gravitas Securities
 

VANCOUVER, BC,  - October 11, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has entered into an engagement agreement with Canaccord Genuity Corp. and Gravitas Securities Inc. to act as co-lead agents on a commercially reasonable efforts basis in respect to a brokered private placement offering of up to 10,000,000 units (the "Units") at a price of $0.40 per Unit for gross proceeds of up to $4,000,000 (the "Offering") subject to completion of satisfactory due diligence. Each Unit will consist of one (1) common share in the capital of the Company (a "Share") and one-half (1/2) transferable common share purchase warrant (each whole warrant, a "Warrant"), with each Warrant exercisable into one additional Share at a price of $0.60 for a period of two years from the date of closing. The Company intends to use the net proceeds of the offering for general working capital, product development and customer acquisition.

“We are delighted to have two of Canada’s leading independent brokerage firms support the Company,” said Dr. Lisa Crossley, CEO of Reliq.

The Company may pay fees and commissions on the Offering within the amount permitted by the policies of the TSX Venture Exchange (the "Exchange"). Closing of the Offering is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including the Exchange. All securities issued in connection with the Offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information contact:
CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Canaccord Genuity Group Inc.:

Through its principal subsidiaries, Canaccord Genuity Group Inc. ("Canaccord") is a leading independent, full-service financial services firm, with operations in two principal segments of the securities industry: wealth management and capital markets. Since its establishment in 1950, Canaccord has been driven by an unwavering commitment to building lasting client relationships. We achieve this by generating value for our individual, institutional and corporate clients through comprehensive investment solutions, brokerage services and investment banking services. Canaccord has offices in 10 countries worldwide, including Wealth Management offices located in Canada, the UK, Guernsey, Jersey, the Isle of Man and Australia. Canaccord Genuity, the international capital markets division, operates in Canada, the US, the UK, France, Ireland, Hong Kong, China, Australia and Dubai. To us there are no foreign markets.™

Canaccord Genuity Group Inc. is publicly traded under the symbol CF on the TSX.

About Gravitas Securities Inc.:

Gravitas is known for sophisticated sector expertise, tactical individuals with a commitment to excellence, global integration and innovation, and as a leading independent wealth management and capital markets firm. Gravitas provides a wide range of investment mandates and services for retail and corporate clients globally from offices in Toronto, Vancouver and Calgary, and is represented in the United States through its FINRA (Financial Industry Regulatory Authority) representative, Gravitas Capital International, in New York and San Francisco.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.


Source: Reliq Health Technologies Inc.

 

Reliq Health Technologies Reaches First Major Milestone of 1,000 Patients Live on Its Remote Patient Monitoring and Telemedicine Platform
 

VANCOUVER, BC,  - October 5, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it now has 1,000 paid subscribers using its chronic care management, remote patient monitoring and telemedicine solution, representing recurring monthly revenue of US$50,000/month.

“We are excited to announce that we now have 1,000 patients live on our platform,” said Dr. Lisa Crossley, CEO of Reliq Health. “This is a critical milestone for Reliq as we move forward with our roll out to over 40,000 patients in accordance with our previously-announced contracts with Paz Home Health, LLC (Pharr, TX) and Rio Grande Valley Health Alliance, LLC (McAllen, TX). We expect to enroll at least 1,000 new patients per month through 2018 with these two contracts, which together are worth over US$26 Million annually in recurring revenue at full deployment.”

Reliq’s digital health solution provides high quality virtual care in the community by creating a “virtual hospital ward” within the patient’s home, automatically collecting vital signs and tracking medication adherence. Reliq’s interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness activities. Reliq’s two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions. The Reliq Health cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs and preventing costly and disruptive hospital readmissions and ER visits.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements". We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

For further information contact:

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

SOURCE: Reliq Health Technologies Inc.

 

Reliq Health Technologies Announces Subscribers Have Voluntarily Extended Hold Period of June 2017 Private Placement
 

VANCOUVER, BC,  - Sept. 28, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, would like provide clarification on the news released issued, June 22nd, 2017, in regards to the private placement at a price of $0.11 per Unit (the “Units”) for a gross proceeds of $736,092.00. All of the subscribers of the said financing have agreed to a voluntary extended hold period of 6 months, to December 22, 2017, from its previous 4 month hold period which would have had a free trading date of October 22, 2017.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information contact:

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

Source: Reliq Health Technologies Inc.

 

Reliq Health Announces Receipt of $200,000 USD Payment from NextGen Applications LLC, San Antonio, TX
 

VANCOUVER, BC,  - Sept. 19, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has received the first payment of US$200,000 from NextGen Applications LLC of San Antonio, TX (the “NextGen” - NextGenApplicationsLLC.com -  info@nextgenapplicationsllc.com) per the contract between Reliq and NextGen. The contract, whose total value is $1.22 Million USD, provides NextGen with professional services and a limited license to Reliq’s proprietary iUGO Health platform, specifically for the development of a consumer focused mobile health app (the “mTelecare App”), providing service to the greater San Antonio area before expanding elsewhere throughout the U.S.

“We are excited to be part of NextGen’s initiative to improve health outcomes and enhance access to care,” said Dr. Lisa Crossley, CEO of Reliq Health. “Our virtual care platform uses a high tech, low touch approach to provide high quality healthcare in the home while reducing the cost of care delivery. Working in conjunction with NextGen Applications, we will be able to leverage our existing platform to create a customized mobile health app that will allow the residents of San Antonio and elsewhere to proactively manage their own health.”

“NextGen’s partnership with Reliq Health will allow us to utilize their existing mHealth platform to provide a novel, innovative mobile healthcare solution to the citizens of San Antonio and surrounding area,” said a spokesperson of NextGen Applications. “The resulting mTelecare mobile app will provide a telemedicine platform that connects patients to doctors and nurses anywhere where there is internet access. mTelecare will support secure video consults for patients with doctors and nurses, providing patients with professional care from the comfort of their own home. The mTelecare app will also provide automated prescription refills, search tools for healthcare services, a personalized health calendar with push notifications, reminders and a suite of billing and payment tools. mTelecare will provide greater access to healthcare, while at the same time reducing healthcare costs.”

The City of San Antonio, Texas is the seventh most populated city in the United States and the second most populated city in Texas, with a population of over 1.4 Million residents.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

For further information contact:

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

SOURCE: Reliq Health Technologies Inc.

 

Reliq Health Announces Appointment of Dr. Richard Sztramko as Chief Medical Officer
 


VANCOUVER, BC,  - Sept. 14, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that Dr. Richard Sztramko has joined the company as its Chief Medical Officer, working out of the Company’s operational headquarters in Hamilton, Ontario.

“We are thrilled to have a physician with Dr. Sztramko’s experience and clinical expertise join our team,” said Dr. Lisa Crossley, CEO of Reliq Health. “His background in Geriatrics and General Internal Medicine and his entrepreneurial experience in the eHealth space will make him an invaluable resource for the Company and for our customers. As we roll out our platform to >48,000 patients at Paz Home Health (Pharr, TX) and the Rio Grande Valley Health Alliance Accountable Care Organization (McAllen, TX) and bring on new customers in the future, Dr. Sztramko’s clinical background will help us ensure that our products comprehensively support clinicians’ workflows while delivering best in class virtual healthcare to their patients.”

“I’m very excited about working with the rest of the Reliq Health team to provide innovative, user-friendly virtual care and telemedicine solutions to patients in the community,” said Dr. Sztramko. “Studies consistently show that providing patients with the tools they need for self-management of their chronic conditions produces better health outcomes and reduces healthcare costs. Reliq’s remote patient monitoring system quickly and easily collects sophisticated health data from patients in their own homes. The secure, cloud-based care collaboration platform provides the clinical care team, patient and family members with real-time access to patient health information including trends over time. This helps clinicians like myself identify high risk patients and intervene early, before a serious complication develops, improving health outcomes, preventing readmissions and ER visits, reducing healthcare costs and increasing patient and family satisfaction.”

Dr. Sztramko practices Geriatric and General Internal Medicine at St. Peter’s, Hamilton General, and Juravinski Hospitals in Hamilton, Ontario, Canada. Prior to joining Reliq Health he co-founded Virtual Ward, a startup focused on healthcare provider communication within hospitals, and created an online education tool for patients with Dementia and their caregivers (iGeriCare).

Reliq’s digital health solution provides high quality virtual care in the community by creating a “virtual hospital ward” within the patient’s home, automatically collecting vital signs and tracking medication adherence. Reliq’s interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled “wearables” and perform prescribed rehab or fitness activities. Reliq’s two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions. The Reliq Health cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs and preventing costly and disruptive hospital readmissions and ER visits.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

For further information contact:

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.


Source: Reliq Health Technologies Inc.

 

Reliq Health Technologies Announces Go-Live with Paz Home Health, USA - >$6MMUSD in Annual Recurring Revenue at Full Deployment
 


VANCOUVER, BC,  - Aug. 17, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce the go-live of remote patient monitoring, care coordination and telemedicine platform with their Rio Grande Valley Health Alliance, LLC (RGVHA) in McAllen, Texas. The Company has begun enrolling the first of RGVHA’s >30,000 Primary Care patients. The Company expects to add >500 patients to the platform each month going forward, generating over $20 Million USD in recurring annual revenue at full deployment.

“We are excited to be working with Rio Grande Valley Health Alliance (RGVHA) to support care coordination across multiple clinical settings, improving health outcomes and reducing the cost of care delivery for their patients,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Reliq’s remote patient monitoring system quickly and easily collects comprehensive health data from patients in their own homes. Our secure, cloud-based care collaboration platform provides the clinical care team, patient and family members with real-time access to patient health information including trends over time. This helps the care team identify patients whose condition is becoming unstable and intervene early, before a serious complication develops requiring an ER visit or hospital admission. The care coordination portal allows patients and their loved ones to clearly see how compliance with prescribed medication and lifestyle changes affect the patient’s health, improving patient engagement and patient- and family-reported satisfaction.”

“Our mission at Rio Grande Valley Health Alliance is to provide better, more efficient care for our patients as an Accountable Care Organization,” said Dr. Luis Delgado, Jr., President. “We are excited to be working with Reliq Health to ensure that our patients receive the best possible care, and that we as their physicians are alerted immediately when patients need additional attention. This is critical to reducing hospital readmissions, ensuring patients successfully transition home after a hospital stay, and preventing medication confusion for complex patients. Reliq’s telemedicine platform will allow us to provide patients who are not able to travel to appointments with secure video consults in the comfort of their own homes, improving access to care for patients in remote and rural communities.”

Rio Grande Valley Health Alliance, LLC (www.rgvha.org) is an Accountable Care Organization (ACO). The group is comprised of 17 primary care physicians who are working with Medicare to provide better coordinated care to Medicare Fee-for-Service patients. The aim of the ACO is to deliver high-quality care and lower growth in health care expenditures. The ACO is made up of 15 independent practices focusing on primary care, and currently has over 30,000 registered patients.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

For further information contact:

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

SOURCE: Reliq Health Technologies Inc.

 

Reliq Health Technologies Announces Go-Live with Paz Home Health, USA - >$6MMUSD in Annual Recurring Revenue at Full Deployment
 


VANCOUVER, BC,  - Aug. 01, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the Community-Based Healthcare market, is pleased to announce the go-live of its remote patient monitoring and telemedicine solution with Paz Home Health LLC in Texas. The Company has begun enrolling the first of Paz’s >10,000 patients. The Company expects to add >500 Paz Home Health patients to the platform each month going forward, generating over $6 Million in recurring annual revenue at full deployment.

“We are excited to be implementing our virtual care platform in Texas with Paz Home Health,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Reliq’s remote patient monitoring system quickly and easily collects sophisticated health data from patients in their own homes. Our virtual care platform was designed to reduce readmissions and improve health outcomes. Reliq’s technology allows Paz Home Health’s patients to receive high quality care from the comfort of their own homes, reducing the cost of care delivery and increasing patient and family satisfaction.”

“Our mission at Paz Home Health is to provide peace of mind for patients and their loved ones,” said Dayana Bermea, CEO. “We are excited to be working with Reliq Health to support our care providers in their day-to-day workflow, freeing up more time for patient care. Reliq Health’s cloud-based portal will allow our clients’ family members to access real-time information about their loved one’s health status, care team and home visit schedule. Patients and their families can feel secure knowing that the Reliq Health system will continuously monitor the patient at home and summon emergency services if needed. At Paz Home Health we are always striving to provide our clients with best in class home healthcare.”

Paz Home Health LLC is a home care agency headquartered in Pharr, Texas that provides care to over 10,000 patients across 16 counties in southern Texas. Paz Home Health delivers in-home care from Registered and Licensed Vocational Nurses, Physical and Occupational Therapists, Medical Social Workers and Dieticians. The company also offers telemonitoring services to connect patients with their care team from the comfort of their own homes. Paz Home Health’s caring and qualified healthcare providers are committed to supporting patients and families who are coping with chronic conditions like Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes, recovering at home from surgery or injuries, and seniors who are aging in place.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

For further information contact:

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

Source: Reliq Health Technologies Inc.

 

Reliq Health Provides Corporate Update
 


VANCOUVER, BC,  -06/23/17 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announced that further to its news release dated June 9, 2017 and June 22, 2017, the Company has received final TSX Venture Exchange approval on the non-brokered private placement of 6,937,200 Units (the "Units") of the Company at a price of $0.11 per Unit for gross proceeds of $763,092.00.

Each Unit each consists of one (1) common share (the "Common Share") and one half (1/2) transferrable share purchase warrant (the "Warrant"). Each of the 3,468,600 warrants entitles the holder thereof to purchase one (1) additional Common Share.

The subscribers to the private placement agreed to a voluntary 6 month hold period on securities issued.

Total Pro Group involvement for 4,546,200 Units in the amount of $500,000.00 was subscribed for by one individual.

ON BEHALF OF THE BOARD

Dr. Lisa Crossley, CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com

Source: Reliq Health Technologies Inc.
 

Reliq Health Announces Closing of Oversubscribed Non-Brokered Private Placement with Gravitas Securities as Exclusive Financial Advisors
 


VANCOUVER, BC,  - 06/22/17 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announced that further to its news release dated June 9, 2017, it successfully closed an oversubscribed non-brokered private placement of 6,937,200 Units (the "Units") of the Company at a price of $0.11 per Unit for gross proceeds of $763,092.00.

Each Unit each consists of one (1) common share (the "Common Share") and one half (1/2) transferrable share purchase warrant (the "Warrant"). Each of the 3,468,600 warrants entitles the holder thereof to purchase one (1) additional Common Share on or before June 21, 2019 at a price of CDN$0.165 per Common Share.

"We're very pleased to complete a successful oversubscribed offering," said Dr. Lisa Crossley, CEO of Reliq. "Gravitas played an instrumental role in the success of the private placement as exclusive advisor."

In accordance with the policies of the TSX Venture Exchange, the Company paid Finders' Fees of an aggregate of $61,047.36 in cash and an aggregate of 554,976 finder warrants (the "Finder Warrant"). Each Finder Warrant will entitle the holder thereof to purchase one (1) additional Common Share on or before June 21, 2019 at a price of CDN$0.165 per Common Share.

The securities issued are subject to a 4 month hold period that expires on October 22, 2017.

About Gravitas Securities Inc.

Gravitas is known for sophisticated sector expertise, tactical individuals with a commitment to excellence, global integration and innovation, and as a leading independent wealth management and capital markets firm. Gravitas provides a wide range of investment mandates and services for retail and corporate clients globally from offices in Toronto, Vancouver, and Calgary, and is represented in the United States through its FINRA representative, Gravitas Capital International, in New York and San Francisco.

ON BEHALF OF THE BOARD

Dr. Lisa Crossley, CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com

Source: Reliq Health Technologies Inc.
 

Reliq Health Technologies Corporate Update
 


VANCOUVER, BC,  - April 21, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that further to the Company's news releases dated March 29, 2017 and April 20, 2017 the Company has received TSX Venture Exchange (the "Exchange") final approval and closed the convertible debenture financing (the "Financing") for gross proceeds of $762,304.97.

All or any portion of the principal amount under the Loans are convertible by the Lenders into units (the "Units") of the Company at any time before the maturity date at a conversion price per Unit of $0.13. Each Unit consists of one (1) common share in the capital of the Company (a "Common Share") and one-half (1/2) share purchase warrant (a "Warrant"). Each full Warrant entitles the holder to purchase one additional Common Share in the capital of the Company (a "Warrant Share") at a price of $0.20 per Warrant Share for a period of thirty-six (36) months from the date of conversion.

The funds received will be used by the Company for ongoing corporate and general working capital purposes.

Subscribers of the Financing have agreed to a voluntary hold period of 6 months.

In accordance with the policies of the TSX Venture Exchange, the Company paid a Finders' Fee of an aggregate of $15,280.00 and 350,000 finders warrants. Each Finder's Warrant entitles the Finder to acquire one common share at a price of $0.20 for a period of 12 months, expiring on April 21, 2018.

As a subscriber to the Financing, Aman Thindal, a Director and Officer of the Issuer may acquire directly or indirectly 769,230 Units upon conversion of the convertible debenture. The participation by an insider in the Financing is considered to be a "related party transaction" as defined under Multilateral Instrument 61-101 ("MI 61-101"). The transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of the securities being issued nor the consideration being paid exceeds 25% of the Company's market capitalization.

Company Overview

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq's powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. Our platform provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

ON BEHALF OF THE BOARD

Dr. Lisa Crossley, CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

Renmark Financial Communications Inc.
Laura Welsh
lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com

Source: Reliq Health Technologies Inc.

 

Reliq Health Technologies Announces Paid Pilot with Rio Grande Valley Health Alliance (McAllen, Texas), Primary Care Provider to over 30,000 Patients
 


VANCOUVER, BC,  - Apr 6, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has signed an agreement with Rio Grande Valley Health Alliance, LLC in McAllen, Texas to pilot Reliq's remote patient monitoring, care coordination and telemedicine platform with their primary care patients. The pilot will go live in May, 2017.

"We are excited to be working with Rio Grande Valley Health Alliance (RGVHA) to support care coordination across multiple clinical settings, improving health outcomes and reducing the cost of care delivery for their patients," said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. "Reliq's remote patient monitoring system quickly and easily collects comprehensive health data from patients in their own homes. Our secure, cloud-based care collaboration platform provides the clinical care team, patient and family members with real-time access to patient health information including trends over time. This helps the care team identify patients whose condition is becoming unstable and intervene early, before a serious complication develops requiring an ER visit or hospital admission. The care coordination portal allows patients and their loved ones to clearly see how compliance with prescribed medication and lifestyle changes affect the patient's health, improving patient engagement and patient- and family-reported satisfaction."

"Our mission at Rio Grande Valley Health Alliance is to provide better, more efficient care for our patients as an Accountable Care Organization," said Dr. Luis Delgado, Jr., President. "We are excited to be working with Reliq Health to ensure that our patients receive the best possible care, and that we as their physicians are alerted immediately when patients need additional attention. This is critical to reducing hospital readmissions, ensuring patients successfully transition home after a hospital stay, and preventing medication confusion for complex patients. Reliq's telemedicine platform will allow us to provide patients who are not able to travel to appointments with secure video appointments in the comfort of their own homes, improving access to care for patients in remote and rural communities."

Rio Grande Valley Health Alliance, LLC (www.rgvha.org) is an Accountable Care Organization (ACO). The group is comprised of 17 primary care physicians who are working with Medicare to provide better coordinated care to Medicare Fee-for-Service patients. The aim of the ACO is to deliver high-quality care and lower growth in health care expenditures. The ACO is made up of 15 independent practices focusing on primary care, and currently has over 30,000 registered patients.

ON BEHALF OF THE BOARD

Dr. Lisa Crossley, CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

Renmark Financial Communications Inc.
Laura Welsh
(416) 644-2020 or (514) 939-3989
lwelsh@renmarkfinancial.com
www.renmarkfinancial.com
CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com

Source: Reliq Health Technologies Inc.
 

Reliq Health Technologies Corporate Update
 


VANCOUVER, BC,  - Mar 29, 2017 - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to provide the following corporate update to current and future shareholders surrounding the recent developments at the Company.

Contracts and Pilot Programs

Reliq has launched a portfolio of remote patient monitoring, care collaboration and telemedicine solutions and has secured the following contracts and pilots:

Reliq has secured a contract with the Paz Home Health in McAllen, Texas that is expected to generate over US$6 million in recurring annual revenue by 2018. Under the terms of the contract, Reliq will provide its remote patient monitoring and care collaboration platform to Paz's homecare providers and 10,000+ patients. The first 500 patients are expected to go live on the platform in June 2017 ramping up to the full 10,000+ patient population by the end of Q1 2018, corresponding to recurring revenue of over US$500,000/month.
Reliq has also secured a contract with the City of San Antonio, Texas to provide a white-labelled version of Reliq's platform to proactively support the health and wellness of the City's 1.4 million residents. The majority of the revenue from this contract is expected to be received between Q2 and Q4 2017.
The Company is currently piloting its software with the National Health Service (NHS) England at Imperial College Hospital, London, UK. The NHS is the largest single payer healthcare system worldwide, providing coverage for over 54 million UK residents. The pilot will end in Q3 2017.
Reliq has an ongoing pilot with Florida-based Sacred Heart Health System (a five-hospital regional healthcare network). Sacred Heart admits more than 30,000 patients annually and is a part of Ascension Health - the largest Catholic, non-profit health care system in the US and one of the largest global healthcare networks. The pilot will conclude in late Q2 2017.
The Company also has an ongoing pilot with The Feldman Institute in Baton Rouge, LA, an interventional pain management clinic that performs thousands of pain management surgeries annually. The pilot is expected to conclude in April 2017.
Reliq will be launching a pilot with Hamilton Health Sciences (HHS) in Hamilton, ON in April 2017. HHS is a five-hospital network that treats over 50,000 patients and performs over 28,000 surgeries each year.
Cannabis Business Initiatives

Recently, Reliq signed a Memorandum of Understanding (MoU) with Invictus MD Strategies Corp. (IMH.CN) (IVITF) to provide Poda (an Invictus portfolio company) with an app its customers can use to track and manage their medical marijuana usage.
Reliq is building a secure clinical database designed to systematically anonymize, aggregate and analyze data collected from medical marijuana patients using Reliq's patient apps. The anonymized clinical data will be used to statistically correlate variables such as dosage, strain and mode of administration with symptom relief and side effects. Ultimately this efficacy and safety data can be used to help identify the optimal strain and dosage for a given patient's specific clinical condition.
Upcoming milestones in the next 6-12 months:

Reliq is focused on continuing to secure new contracts with home care agencies, assisted living facilities and hospitals in the United States and Canada
The Company expects to achieve profitability by the end of 2017
Cash Position

The Company has received $164,416 from the exercise of warrants as of March 28, 2017. Additionally, due to investor interest the Company intends to close a convertible debenture of up to $700,000, subject to the TSX Venture Exchange approval. The Company's CFO will subscribe to $100,000 of this debenture. Subscribers of the debenture have agreed to a voluntary hold period of 6 months.

Company Overview

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq's powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. Our platform provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

Renmark Financial Communications Inc.
Laura Welsh
lwelsh@renmarkfinancial.com
(416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com



Source: Reliq Health Technologies Inc.

 

 

Reliq Health Technologies Signs Agreement with Paz Home Health, TX, USA to Provide Remote Patient Monitoring to >10,000 Home Care Clients
 


VANCOUVER, BC,  - February 16, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on creating innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has signed an agreement with Paz Home Health LLC in Texas to provide Reliq’s hardware and software solutions to their home care clients. Patient enrollment will begin in March 2017 with 500 Paz Home Health patients, building to over 10,000 patients and over $6 Million in recurring annual revenue in 2018.

“We are very pleased to be working with Paz Home Health to deliver high quality care to patients in the home,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Reliq’s remote patient monitoring system quickly and easily collects sophisticated health data from patients in their own homes. Our secure, cloud-based care collaboration platform provides the clinical care team, patient and family members with real-time access to patient health information including trends over time. This helps the care team identify patients whose condition is becoming unstable and intervene early, before a serious complication develops. Patients and their loved ones are able to clearly see how compliance with prescribed medication and lifestyle changes affect the patient’s health measures, improving patient engagement and patient- and family-reported satisfaction. Reliq’s virtual care platform was designed to reduce readmissions and improve health outcomes. Our technology allows patients to receive high quality care from the comfort of their own homes, reducing the cost of care delivery and increasing patient and family satisfaction.”

“Our mission at Paz Home Health is to provide peace of mind for patients and their loved ones,” said Dayana Bermea, CEO. “We are excited to be working with Reliq Health to support our care providers in their day-to-day workflow, freeing up more time for patient care. Reliq Health’s cloud-based portal will allow our clients’ family members to access real-time information about their loved one’s health status, care team and home visit schedule. Patients and their families can feel secure knowing that the Reliq Health system will continuously monitor the patient at home and summon emergency services if needed. At Paz Home Health we are always striving to provide our clients with best in class home healthcare.”

Paz Home Health LLC is a home care agency headquartered in Pharr, Texas that provides care to over 10,000 patients across 16 counties in southern Texas. Paz Home Health delivers in-home care from Registered and Licensed Vocational Nurses, Physical and Occupational Therapists, Medical Social Workers and Dieticians. The company also offers telemonitoring services to connect patients with their care team from the comfort of their own homes. Paz Home Health’s caring and qualified healthcare providers are committed to supporting patients and families who are coping with chronic conditions like Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes, recovering at home from surgery or injuries, and seniors who are aging in place.


ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information contact:

Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.


 

Reliq Health Technologies and Invictus MD Strategies Corp. Sign MOU to Collaborate on App for Cannabis Prescribers, Patients and Consumers
 


VANCOUVER, BC,  - February 7, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS) (“Invictus MD”) to develop a mobile application for cannabis patients and consumers and their clinical care teams.

Reliq Health, a healthcare technology company focused on developing innovative mobile health and telemedicine solutions, has developed a novel SaaS (software as a service) solution for the community health care market. The solution provides automated remote patient monitoring in the home and secure cloud-based communication, care planning and collaboration for all members of the patient’s circle of care. Reliq’s secure platform allows clinicians to collect comprehensive data on patients’ clinical conditions, medication usage, symptoms, side effects and behaviours – creating a wealth of population health data.

“Studies consistently show that providing patients with the tools they need for self-management of their health conditions produces better health outcomes and reduces healthcare costs. Cannabis is prescribed to treat a wide range of conditions including arthritis, glaucoma, side effects from chemotherapy, chronic pain, multiple sclerosis and post-traumatic stress disorder. Our cannabis app allows patients to track usage and record symptoms specific to their clinical condition, allowing patients and their care providers to determine optimum strain, dosing and mode of administration. Our platform will improve access to care by connecting patients with physicians in their community who have experience with medical marijuana, and supports physician-approved automated prescription refills through participating producers,” said Dr. Lisa Crossley, CEO of Reliq.

Invictus MD’s Chairman and CEO, Dan Kriznic, said, “Our wholly owned subsidiary: Poda Technologies Ltd. (“Poda”) is set for a launch in Q2 2017 of its Poda Pod vaporizer product which will provide an effective, reliable and convenient way to vaporize cannabis that is designed to appeal to modern retail and medical consumers.” The Poda Pod vaporizer product, made with medical-grade components, has been designed to connect to users’ smartphones via Bluetooth to provide real time information about dosage, product characteristics, track remaining contents, find vendors nearby, and customize their experience. Agreements are being negotiated to license the PODA products to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) and licensed producers in Canada, helping those producers better reach and serve consumers with convenient, refillable devices.

Mr. Kriznic added, “Invictus MD is excited and committed to working collaboratively with Reliq on this innovative mobile application to explore how Reliq’s solution can support Invictus’ commitment to its patients and consumers of cannabis products. Reliq’s technology platform will give Invictus the ability to collect relevant anonymized consumer data such as usage trends, frequency of usage and other relevant insights to improve the overall experience for medical marijuana patients.”

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

 

Reliq Health Technologies Announces Development of Mobile App for Cannabis Patients
 


VANCOUVER, BC,  - January 19, 2017 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has developed a novel mobile application to support patients who have been prescribed medical marijuana.

"As part of our commitment to high quality patient care in the home, Reliq Health is proud to be launching a mobile application that will help medical marijuana consumers track their usage and record their symptoms," said Dr. Lisa Crossley, CEO of Reliq Health. "Studies consistently show that providing patients with the tools they need for self-management of their health conditions produces better health outcomes and reduces healthcare costs. Cannabis is prescribed to treat a wide range of conditions including arthritis, glaucoma, side effects from chemotherapy, chronic pain, multiple sclerosis and post-traumatic stress disorder. Our app allows patients to track cannabis usage and record symptoms specific to their clinical condition, allowing patients and their care providers to determine optimum strain, dosing and mode of administration. Our platform improves access to care by connecting patients with physicians in their community who have experience with medical marijuana, and supports physician-approved automated prescription refills through participating producers."

Reliq intends to market the app to medical cannabis companies in Canada and other jurisdictions where cannabis can be legally prescribed.

ON BEHALF OF THE BOARD

Dr. Lisa Crossley, CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com


Source: Reliq Health Technologies Inc.

 

Reliq Health Technologies Opens Office in London, UK to Support Pilot at Imperial College Hospital and Further Expansion into the European Market
 


VANCOUVER, BC,  - December 8, 2016 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has opened an office in the UK to support Reliq's expansion into the European market.

"We are very pleased to be opening an office in London, England in response to strong interest from the UK market," said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. "Reliq recently launched a pilot with the NHS England at Imperial College Hospital in London to validate the use of our remote patient monitoring and care collaboration solution for patients with chronic conditions. Opening an office in the UK allows us to better support this pilot and acquire new customers in the UK and the rest of Europe. Reliq's virtual care platform was designed to reduce readmissions and improve health outcomes for patients with chronic conditions like Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes. Our technology allows patients to receive high quality care from the comfort of their own homes, reducing the cost of care delivery and increasing patient and family satisfaction."

Currently there are over 15 million people in England living with at least one long-term health condition. In addition to the impact on people's lives, long-term condition management accounts for half of all General Practitioner appointments and 70% of hospital bed days in the UK. Reliq Health's proprietary hardware and software supports patients and their caregivers in the home, providing remote vitals monitoring with alerts to clinicians as needed, audible reminders to improve patient compliance with prescribed medication regimens and lifestyle changes, tailored patient education and secure communication with the entire care team.

Reliq's UK office is located at Impact Hub Westminster, 1st Floor New Zealand House, 80 Haymarket, London SW1Y 4TE. The entire funding for the UK office was provided by the UK Department of International Trade's Global Entrepreneur Programme, which supports entrepreneurs and early stage technology businesses that wish to locate in the UK.

ON BEHALF OF THE BOARD

"Dr. Lisa Crossley"

CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE Reliq Health Technologies Inc.

 

 

Reliq Health Technologies Announces Patient Enrollment at The Feldman Institute in Louisiana for Pilot to Improve Access to Care for Interventional Pain Management Patients Post-Surgery
 


VANCOUVER, BC,  - December 1, 2016 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has begun enrolling patients for the pilot of its remote patient monitoring and secure communication solution with The Feldman Institute in Baton Rouge, Louisiana. The pilot will evaluate the use of Reliq Health’s technology with patients who have been discharged home after interventional pain management surgery, or have returned to their homes between treatments at The Feldman Institute.

“We are very pleased to be enrolling patients and launching our pilot of the Reliq Health platform with The Feldman Institute,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Our virtual care solution allows patients to receive high quality follow up care from the comfort of their own homes. Patients can communicate with their care team at The Feldman Institute using Reliq’s cloud-based secure messaging, videoconferencing and virtual visits. The Reliq Health cloud provides access to patient education materials and instructional videos, empowering patients and their families to actively participate in their own care at home. We look forward to working with The Feldman Institute to improve treatment outcomes, reduce the risk of post-surgical complications and increase access to specialized pain management care for their chronic pain patients.”

“One of our key goals at The Feldman Institute is to provide our patients with compassionate, accessible healthcare.” said Dr. Arnold E. Feldman, Medical Director at The Feldman Institute and First Choice Surgery Center. “Our pilot with Reliq Health is designed to validate the use of their virtual care solution to help our patients better manage and document their symptoms in the home, and facilitate secure and timely communication between patients and family members and their care team at The Feldman Institute. Many of our patients travel great distances to receive cutting edge pain management surgery and other treatments at our facility. With Reliq Health’s remote patient monitoring and secure communication platform we can continue to provide high quality care to these patients even after they return home.”

The Feldman Institute's mission is to relieve chronic pain and restore health, comfort and quality of life in a collaborative and compassionate environment. The Feldman Institute is committed to eliminating pain through research and innovation while working closely with each patient to find their appropriate level of care. The Feldman Institute is dedicated to helping its patients through a comprehensive program of interventional pain management. The Feldman Institute specializes in performing minimally invasive, outpatient, and Endoscopic Discectomy procedures to address problems such as herniated discs, bulging discs, or ruptured discs. These advanced procedures are alternatives to open back and neck surgery and do not require general anesthesia. Patients undergoing these procedures experience far less trauma and a much shorter recovery time. The diagnosis and treatment techniques offered at the Feldman Institute represent the leading edge of recent medical advances.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.
 

 

Reliq Health Technologies Announces Patient Enrollment at Sacred Heart Health System in Florida for Pilot to Reduce Readmissions and Improve Health Outcomes for Congestive Heart Failure Patients
 


VANCOUVER, BC,  - November 10, 2016 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has begun enrolling patients for the pilot of its remote patient monitoring and care collaboration solution with Sacred Heart Health System in Florida.

The pilot is specifically aimed at reducing readmissions for Sacred Heart's Congestive Heart Failure (the "CHF") patients. CHF affects over 6 Million Americans, and over 21% of all patients in the US who are admitted to hospital for CHF will be readmitted within 30 days of discharge. All-cause 30-day readmissions cost the US healthcare system over $41 Billion annually.

Reliq's digital health solution reduces readmissions by creating a "virtual hospital ward" within the patient's home, automatically collecting vital signs and tracking medication adherence. Reliq's interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled "wearables" and perform prescribed rehab or fitness activities. Reliq's two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions. The Reliq Health cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs and preventing costly and disruptive hospital readmissions and ER visits.

"We are very excited to be enrolling patients and launching our pilot with Sacred Heart Health System in Florida," said Dr. Lisa Crossley, CEO of Reliq Health. "Studies consistently show that providing patients with the tools they need for self-management of their chronic conditions produces better health outcomes and reduces healthcare costs. Reliq's remote patient monitoring system quickly and easily collects sophisticated health data from patients in their own homes. Our secure, cloud-based care collaboration platform provides the clinical care team, patient and family members with real-time access to patient health information including trends over time. This helps the care team identify high risk patients and intervene early, before a serious complication develops. Patients and their loved ones are able to clearly see how compliance with prescribed medication and lifestyle changes affect the patient's health measures, improving patient engagement and patient- and family-reported satisfaction."

Sacred Heart Health System is Northwest Florida's leading provider of high-quality health care to children and adults. The hub of the Sacred Heart system is its 566-bed Sacred Heart Hospital in Pensacola. The facilities in Pensacola include The Children's Hospital at Sacred Heart, a Level II Trauma Center, a Cancer Center affiliated with MD Anderson Cancer Network, the area's only program specializing in maternal-fetal medicine, and a cardiovascular program ranked as one of the top 50 in the nation by Truven Analytics. The Health System also includes Sacred Heart Hospital on the Emerald Coast, a 58-bed community hospital near Destin, Sacred Heart Hospital on the Gulf, a 19-bed hospital, in Port St. Joe, and Sacred Heart Medical Group, a large regional network of primary care and specialty physicians with offices across seven coastal counties between Gulf Shores, Ala. and Apalachicola, FL. Sacred Heart is part of Ascension Health, the nation's largest system of Catholic and non-profit health care facilities.

ON BEHALF OF THE BOARD

Dr. Lisa Crossley, CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com


Source: Reliq Health Technologies Inc.

 

Reliq Health Technologies Announces Patient Enrollment at Imperial College Hospital London for Pilot with National Health Service England for Remote Patient Monitoring and Care Collaboration
 


VANCOUVER, BC,  - November 10, 2016 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has begun enrolling patients in the pilot of its remote patient monitoring and care collaboration solution with the NHS England.

“We are very excited to be launching our pilot with the NHS England and enrolling patients at our pilot site, Imperial College Hospital, London, UK.” said Dr. Lisa Crossley, CEO of Reliq Health. “The goal of this pilot is to demonstrate the value of Reliq Health’s self-care solution in improving health outcomes and reducing the cost of care delivery for chronic disease patients after they are discharged home from hospital. Our platform uses a combination of secure cloud-based software, voice technology, wearables and sensors to support patients and their loved ones in proactively managing their chronic conditions at home, reducing exacerbations and disease-related complications, decreasing healthcare costs and enhancing patient and family satisfaction”.

The NHS England is the largest single-payer healthcare system in the world, with an annual budget of over 100 Billion. There are over 15 million patients in England who are coping with at least one long-term health condition. These chronic conditions not only negatively impact patients’ quality of life, but also account for over half of all General Practitioner (GP) appointments and 70% of hospital bed days. NHS England has estimated that improvements in self-care in this population could result in 584m in savings by 2021. Reliq’s digital health solution creates a fully automated “virtual hospital ward” in the patient’s home, providing real-time tracking of patients’ vital signs, medication adherence, and movements within the home. The Reliq Health platform provides patients with audible alerts and reminders to collect their vitals, take their medications and perform prescribed rehab or fitness activities to support proactive self-care. Patient education materials are also provided through the Reliq Health platform to help patients and their families better understand and manage their chronic conditions.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

 

Reliq Health Technologies Announces Pilot with Hamilton Health Sciences and McMaster University to Pilot Its Remote Patient Monitoring and Care Collaboration Solution


VANCOUVER, BC,  - November 3, 2016 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has signed an agreement with Hamilton Health Sciences and McMaster University in Hamilton, ON to pilot its remote patient monitoring and care collaboration solution. The pilot is expected to commence in February 2017.

"We are very excited to work with Hamilton Health Sciences (the "HHS") and McMaster University to improve health outcomes for patients with Peripheral Arterial Disease (the "PAD"). Our collaboration with McMaster and HHS will allow us to deliver a digital health solution for self-care and patient education that is uniquely tailored to the needs of PAD outpatients." said Dr. Lisa Crossley, CEO of Reliq Health. "Our platform uses a high tech, low touch approach to provide high quality healthcare in the home, reducing exacerbations and disease-related complications, decreasing healthcare costs and enhancing patient and family satisfaction".

Peripheral Arterial Disease affects over 800,000 Canadians and over 8 Million Americans. PAD can cause pain, fatigue, poor circulation and slow wound healing in the extremities. Unless properly managed, PAD can lead to significant complications including infection, gangrene and amputations. Reliq Health's proprietary hardware and software supports patients and their caregivers in the home, providing remote monitoring with alerts to clinicians as needed, audible reminders to improve patient compliance with prescribed medication regimens and lifestyle changes, tailored digital patient education materials and secure communication with the entire care team. Studies have consistently shown that providing patients and families with the tools they need to better understand and manage their clinical conditions at home leads to better health outcomes.

ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

SOURCE Reliq Health Technologies Inc.

 

Reliq Health Announces Community Care Pilot with the United Kingdom (UK) National Health Service


VANCOUVER, BC,  - AUGUST 02, 2016 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has been accepted into the National Health Service (NHS) United Kingdom’s (UK’s) Test Beds program and will begin piloting its virtual care technology with a London-area hospital in Q4 2016.

“We are very excited to be piloting Reliq’s community care platform in the UK. Our technology is strongly aligned with the NHS England’s ongoing initiative to improve the management of long term conditions in the community.” said Dr. Lisa Crossley, CEO of Reliq Health. “Our platform uses a high tech, low touch approach to provide high quality healthcare in the home, reducing exacerbations and disease-related complications, decreasing healthcare costs and enhancing patient and family satisfaction. We look forward to participating in the NHS Test Beds program to demonstrate the value of Reliq Health’s technology to patients, caregivers and the health system in the UK”.

The pilot will focus on two of the most common chronic conditions in the UK, congestive heart failure (CHF) and diabetes. Currently there are over 15 million people in England living with at least one long-term health condition. In addition to the impact on people’s lives, long-term condition management accounts for half of all General Practitioner appointments and 70% of hospital bed days in the UK. Reliq Health’s proprietary hardware and software supports patients and their caregivers in the home, providing remote vitals monitoring with alerts to clinicians as needed, audible reminders to improve patient compliance with prescribed medication regimens and lifestyle changes, tailored patient education and secure communication with the entire care team.


ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

Reliq Health Technologies Inc.
#1128 – 789 West Pender Street
Vancouver, B.C., V6C 1H2
Phone: 778-707-6673
Fax: 604-608-3906

SOURCE: Reliq Health Technologies Inc.

 

Brian Storseth Joins Reliq Health Technologies’ Board of Directors


VANCOUVER, BC,  - JULY 28, 2016 / - Reliq Health Technologies Inc. (TSXV:RHT OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce Mr. Brian Storseth has joined the Company’s Board of Directors effective immediately.

Mr. Storseth is a businessman and was a Member of Parliament (MP) with the Conservative Party of Canada for 9 years from 2006 to 2015 – he did not seek re-election in 2016. During his tenure as an MP he served on committees for Aboriginal affairs, agriculture and agri-food.

“Brian is an accomplished business leader and policy expert, having spent 9 years as an MP in the House of Commons. Brian is intimately familiar with issues relevant to Canadian companies such as ours. We are excited to leverage his network and experience in order to further expand Reliq’s footprint in Canada,” said Dr. Lisa Crossley, CEO of Reliq Health.

“I admire how far Reliq has come in a very short period of time and am impressed with the traction the team has achieved with their technology in the United States. I look forward to working with them to introduce the technology to various Provinces, health authorities and other potential users. Using technology like Reliq’s to improve efficiencies, reduce costs and improve the quality of care is the future of healthcare for both publicly and privately funded systems,” said Mr. Brian Storseth.

Mr. Storseth will be granted 250,000 options at $0.15 upon approval from the TSX Venture Exchange.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

Reliq Health Technologies Inc.
#1128 – 789 West Pender Street
Vancouver, B.C., V6C 1H2
Phone: 778-707-6673
Fax: 604-608-3906

SOURCE: Reliq Health Technologies Inc.
 

---------------------------------------

About Reliq Health Technologies:

Reliq Health Technologies is a Vancouver, BC based healthcare technology company that specializes in developing innovative, secure mobile software solutions for the $20 Billion Community Care market. Reliq’s iUGO Health technology platform is a comprehensive hardware and software solution that allows complex patients to receive high quality care in the home, improving health outcomes, enhancing quality of life for patients & families and reducing the cost of care delivery.

iUGO Health
iUGO Health is a wholly-owned subsidiary of Reliq Health Technologies
iUGO Health has built a powerful platform for care coordination and home healthcare that integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, families, clinicians and healthcare administrators. iUGO Health allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. Our platform provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.

Leadership Team
Our leadership team has a strong track record of building successful companies in healthcare and technology.

Dr. Lisa Crossley, PhD., P.Eng.
CEO

Dr. Crossley is an accomplished healthcare technology executive with a proven track record of successfully building and leading global tech companies. She has diverse experience across multiple market segments, including healthcare information technology, therapeutics, medical devices, life science tools and diagnostics. Most recently, Dr. Crossley was CEO of VitalHub Corp., a healthcare IT company that provides clinicians with secure mobile access to comprehensive patient health information. Her prior experience includes leadership positions as CEO of Quantum Dental Technologies and President & CEO of Natrix Separations. Dr. Crossley has raised over $35 Million in venture capital and angel financing, negotiated channel partner agreements with major multinational market leaders and built customer bases in North America, Europe and Asia. She holds a B.Sc. in Anatomy & Cell Biology from McGill University and a B.A.Sc. and Ph.D. in Chemical Engineering from Queen’s University, and is a licensed Professional Engineer in the Province of Ontario. Dr. Crossley currently serves on the Genome Alberta Board of Directors and on the Mitacs Research Council. She has previously acted as a Board Director for the Ontario Bioscience Innovation Organization (OBIO), Viron Therapeutics, Boyd Technologies, and Women in Science and Technology Businesses (WSTB) and has held numerous Advisory Board appointments. She was a member of the Council of Canadian Academies’ Expert Panel commissioned by Industry Canada to conduct a comprehensive assessment of the State of Industrial R&D in Canada.

Giancarlo De Lio
CVO

An experienced entrepreneur, Giancarlo has previously founded numerous successful businesses in the marketing, digital, healthcare and IT markets including his most recent success, VitalHub Corp., which developed a mobile charting application for the enterprise mHealth market. Prior to VitalHub Giancarlo worked at Mount Sinai Hospital in Toronto, developing innovative IT solutions for the clinical teams. Giancarlo holds a B.Sc. in Computer Science from the University of Toronto and an MBA from the University of Toronto’s Rotman School of Management.

Aman Thindal
CFO & Director

Aman Thindal is the Chief Financial Officer at Moseda Technologies Inc. He has over 6 years of experience and knowledge as an independent investor and has provided consulting services to private companies. Prior to Joining Moseda Technologies Inc., Mr. Thindal spent 4 years as a partner and CFO of a Greater Vancouver based private mid-tier real estate development company where he played an active role in land acquisitions, financial management, human resources and marketing of the company’s projects. During his tenure Mr. Thindal helped the company secure over $75,000,000 in both traditional mortgage and private equity financing. Mr. Thindal obtained his Chartered Accountant Designation in 2010 and he holds a Bachelor of Business Administration degree with joint concentration in Accounting and Finance from Simon Fraser University.

Leo Godreault
VP of Products

Leo is a Registered Nurse and a serial entrepreneur with a strong background in Information Technology. Leo has previously founded SmartMED, a healthcare IT company designed to improve the patient and clinician experience. Leo brings a unique combination of IT expertise and clinical experience to the CareKit Health team. Leo holds a BScN from McMaster University and Mohawk College..

SOURCE: www.reliqhealth.com




Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated three thousand nine hundred dollars for Reliq Health Technologies Inc.  news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF Reliq Health Technologies Inc. 

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.